Home › NDC Lookup › RxCUI directory › RxCUI 2640412

0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe — RxCUI 2640412

RxNorm drug concept · Semantic clinical drug
RxCUI 2640412 Semantic clinical drug · SCD ● Current RxNorm concept 5 FDA products 5 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2640412
Official name0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asadalimumab-fkjp 20 MG per 0.4 ML Prefilled Syringe; adalimumab-fkjp 20 MG in 0.4 ML Prefilled Syringe
FDA products mapped5
Package NDCs mapped5
Reported Medicaid activity (SDUD)2,195 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Adalimumab Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Adalimumab is approved for quite a few inflammatory conditions — rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psor...
  • What conditions is adalimumab actually approved to treat?
  • You'll use either an autoinjector pen or a prefilled syringe, depending on what your doctor prescribes. Before injecting, take it out of the refrigerator and let it sit for 15 to 3...
  • How do I give myself this injection at home?
📖 Read our full Adalimumab Injection guide →

🕸️ Concept Web — How 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syring... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe RxCUI 2640412

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Adalimumab 327361
    • Adalimumab-fkjp 2640402
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Hulio 2640406
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Adalimumab Prefilled Syringe 727702
    • Adalimumab-fkjp Prefilled Syringe 2646033
    • Adalimumab Injectable Product 1163691
    • Adalimumab-fkjp Injectable Product 2661140
    • Adalimumab Prefilled Syringe [Hulio] 2640414
    • Adalimumab-fkjp Prefilled Syringe [Hulio] 2655533
    • Hulio Injectable Product 2640408
    • Prefilled Syringe 721656
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Adalimumab-fkjp 50 MG/ML SCDC · 2640403
  • Adalimumab Prefilled Syringe SCDF · 727702
  • Adalimumab-fkjp Prefilled Syringe SCDFP · 2646033
  • Adalimumab Injectable Product SCDG · 1163691
  • Adalimumab-fkjp Injectable Product SCDGP · 2661140

Brand-Name Concepts

  • 0.4 ML adalimumab-fkjp 50 MG/ML Prefilled Syringe [Hulio] SBD · 2640415
  • Adalimumab-fkjp 50 MG/ML [Hulio] SBDC · 2640407
  • Adalimumab Prefilled Syringe [Hulio] SBDF · 2640414
  • Adalimumab-fkjp Prefilled Syringe [Hulio] SBDFP · 2655533
  • Hulio Injectable Product SBDG · 2640408
  • Hulio BN · 2640406

📦 FDA Products & Package NDCs

5 products · 5 package NDCs
5 package NDCs map to RxCUI 2640412 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
83257-0016-42 2 TRAY in 1 KIT (83257-016-42) / 1 KIT in 1 TRAY * 2 TRAY... HULIO Biocon Biologics Inc 2023-12-30
83257-0019-32 2 TRAY in 1 KIT (83257-019-32) / 1 KIT in 1 TRAY * 2 TRAY... HULIO Biocon Biologics Inc 2023-12-30
83257-0020-42 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY... Adalimumab Biocon Biologics Inc 2024-04-15
83257-0021-42 2 TRAY in 1 KIT (83257-021-42) / 1 KIT in 1 TRAY * 2 TRAY... Adalimumab Biocon Biologics Inc 2024-04-15
83257-0022-32 2 TRAY in 1 KIT (83257-022-32) / 1 KIT in 1 TRAY * 2 TRAY... Adalimumab Biocon Biologics Inc 2024-04-15
Observed labelers: Biocon Biologics Inc (5) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.